These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16415339)

  • 1. Improving access to pharmaceuticals in Brazil and Argentina.
    Homedes N; Ugalde A
    Health Policy Plan; 2006 Mar; 21(2):123-31. PubMed ID: 16415339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisource drug policies in Latin America: survey of 10 countries.
    Homedes N; Ugalde A
    Bull World Health Organ; 2005 Jan; 83(1):64-70. PubMed ID: 15682251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The (political) economics of antiretroviral treatment in developing countries.
    Nattrass NJ
    Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What predicts the quality of advanced cancer care in Latin America? A look at five countries: Argentina, Brazil, Cuba, Mexico, and Peru.
    Torres Vigil I; Aday LA; De Lima L; Cleeland CS
    J Pain Symptom Manage; 2007 Sep; 34(3):315-27. PubMed ID: 17616337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harm reduction policies in Argentina: a critical view.
    Epele ME; Pecheny M
    Glob Public Health; 2007; 2(4):342-58. PubMed ID: 19283632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year assessment of joint procurement of pharmaceuticals in the public health sector in Jordan.
    Al-Abbadi I; Qawwas A; Jaafreh M; Abosamen T; Saket M
    Clin Ther; 2009 Jun; 31(6):1335-44. PubMed ID: 19695398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): towards consensus and improved guidance.
    Donoghoe MC; Verster A; Pervilhac C; Williams P
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S5-14. PubMed ID: 18243681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poverty and access to health care in developing countries.
    Peters DH; Garg A; Bloom G; Walker DG; Brieger WR; Rahman MH
    Ann N Y Acad Sci; 2008; 1136():161-71. PubMed ID: 17954679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New forms of citizenship and socio-political inclusion: accessing antiretroviral therapy in a Rio de Janeiro favela.
    Cataldo F
    Sociol Health Illn; 2008 Sep; 30(6):900-12. PubMed ID: 18761510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries.
    Beck EJ; Santas XM; Delay PR
    AIDS; 2008 Jul; 22 Suppl 1():S75-85. PubMed ID: 18664958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brazil may stop HIV drug access; problems also reported from Argentina.
    AIDS Treat News; 1999 Sep; (No 326):5-6. PubMed ID: 11366581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of human parasitic diseases: Context and overview.
    Molyneux DH
    Adv Parasitol; 2006; 61():1-45. PubMed ID: 16735161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost containment through pharmaceutical procurement: a Caribbean case study.
    Huff-Rousselle M; Burnett F
    Int J Health Plann Manage; 1996; 11(2):135-57. PubMed ID: 10172681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The morally uncomfortable global drug gap.
    Cohen-Kohler JC
    Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to medicines in Senegal: results of a sample survey.
    Garenne M; Candau D; Guimier JM; Badiane M; Diop AC; Teulières LC
    Trop Doct; 2006 Jan; 36(1):5-8. PubMed ID: 16483417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality medicines for the poor: experience of the Delhi programme on rational use of drugs.
    Chaudhury RR; Parameswar R; Gupta U; Sharma S; Tekur U; Bapna JS
    Health Policy Plan; 2005 Mar; 20(2):124-36. PubMed ID: 15746221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Argentina, Brazil and Mexico. Biomedical research and the defense of a single standard of attention in developing countries].
    Angeles-Llerenas A; Bello MA; Dirce G; Salinas MA
    Rev Invest Clin; 2004; 56(5):675-85. PubMed ID: 15776872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.